Phencyclidine induces a psychotomimetic state by blocking neurotransmi
ssion at N-methyl-D-aspartic acid (NMDA) receptors. In a double-blind,
placebo-controlled fashion, 14 medicated patients with chronic schizo
phrenia were treated with glycine, a potentiator of NMDA- receptor-med
iated neurotransmission. Significant improvement in negative symptoms
occurred in the group given glycine but not in the group given placebo
, suggesting that potentiation of NMDA-receptor-mediated neurotransmis
sion may represent an affective treatment for neuroleptic-resistant ne
gative symptoms in schizophrenia.